Amgen Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Amgen Inc. (AMGN) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-02-13
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2024-12-31 was $0.00.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2024-09-30 was $0.00.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2024-06-30 was $0.00.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $0.00.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $550.00M, a 50.89% decline from fiscal 2022.
- Amgen Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $1.12B, a 87.32% decline from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $550.00M 10-K · filed 2026-02-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $550.00M 10-Q · filed 2024-10-31 | $1.22B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $550.00M 10-Q · filed 2024-08-07 | $1.22B derived: sum of 3 quarters · filed 2025-02-14 | $1.62B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $550.00M 10-Q · filed 2024-05-03 | $1.22B derived: sum of 2 quarters · filed 2025-02-14 | $1.62B derived: sum of 3 quarters · filed 2025-02-14 | $1.64B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $673.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $1.07B derived: sum of 2 quarters · filed 2025-02-14 | $1.09B derived: sum of 3 quarters · filed 2025-02-14 | $1.12B 10-K · filed 2025-02-14 |
| 2022-09-30 | $400.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $415.00M derived: sum of 2 quarters · filed 2023-10-31 | $447.00M 10-Q · filed 2023-10-31 | $1.35B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $47.00M 10-Q · filed 2023-08-04 | $951.00M derived: sum of 3 quarters · filed 2024-02-14 | $2.35B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $32.00M 10-Q · filed 2023-04-28 | $936.00M derived: sum of 2 quarters · filed 2024-02-14 | $2.33B derived: sum of 3 quarters · filed 2024-02-14 | $5.34B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $904.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $2.30B derived: sum of 2 quarters · filed 2024-02-14 | $5.31B derived: sum of 3 quarters · filed 2024-02-14 | $8.83B 10-K · filed 2024-02-14 |
| 2021-09-30 | $1.40B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $4.40B derived: sum of 2 quarters · filed 2022-11-04 | $7.93B 10-Q · filed 2022-11-04 | $9.97B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $3.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $6.53B 10-Q · filed 2022-08-05 | $8.57B derived: sum of 3 quarters · filed 2023-02-09 | $10.67B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $3.52B 10-Q · filed 2022-04-28 | $5.57B derived: sum of 2 quarters · filed 2023-02-09 | $7.67B derived: sum of 3 quarters · filed 2023-02-09 | $7.79B derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $2.04B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $4.14B derived: sum of 2 quarters · filed 2023-02-09 | $4.27B derived: sum of 3 quarters · filed 2023-02-09 | $4.38B 10-K · filed 2023-02-09 |
| 2020-09-30 | $2.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.23B derived: sum of 2 quarters · filed 2021-11-03 | $2.34B 10-Q · filed 2021-11-03 | $4.45B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $125.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $238.00M 10-Q · filed 2021-08-04 | $2.35B derived: sum of 3 quarters · filed 2022-02-16 | $7.17B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $113.00M 10-Q · filed 2021-04-28 | $2.22B derived: sum of 2 quarters · filed 2022-02-16 | $7.04B derived: sum of 3 quarters · filed 2022-02-16 | $10.21B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $2.11B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $6.93B derived: sum of 2 quarters · filed 2022-02-16 | $10.09B derived: sum of 3 quarters · filed 2022-02-16 | $20.55B 10-K · filed 2022-02-16 |
| 2019-09-30 | $4.82B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $7.99B derived: sum of 2 quarters · filed 2020-10-29 | $18.44B 10-Q · filed 2020-10-29 | $19.97B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $3.16B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $13.62B 10-Q · filed 2020-07-29 | $15.15B derived: sum of 3 quarters · filed 2021-02-09 | $18.04B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $10.46B 10-Q · filed 2020-05-01 | $11.99B derived: sum of 2 quarters · filed 2021-02-09 | $14.87B derived: sum of 3 quarters · filed 2021-02-09 | $14.97B derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $4.42B derived: sum of 2 quarters · filed 2021-02-09 | $4.51B derived: sum of 3 quarters · filed 2021-02-09 | $5.41B 10-K · filed 2021-02-09 |
| 2018-09-30 | $2.89B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $2.98B derived: sum of 2 quarters · filed 2019-10-30 | $3.88B 10-Q · filed 2019-10-30 | $5.29B derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $93.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $993.00M 10-Q · filed 2019-07-31 | $2.40B derived: sum of 3 quarters · filed 2020-02-12 | $3.88B derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $900.00M 10-Q · filed 2019-05-01 | $2.31B derived: sum of 2 quarters · filed 2020-02-12 | $3.79B derived: sum of 3 quarters · filed 2020-02-12 | $5.55B derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $2.89B derived: sum of 2 quarters · filed 2020-02-12 | $4.65B derived: sum of 3 quarters · filed 2020-02-12 | $6.17B 10-K · filed 2020-02-12 |
| 2017-09-30 | $1.48B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $3.24B derived: sum of 2 quarters · filed 2018-10-31 | $4.76B 10-Q · filed 2018-10-31 | $5.29B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $1.76B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $3.28B 10-Q · filed 2018-07-27 | $3.81B derived: sum of 3 quarters · filed 2019-02-13 | $4.40B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $1.53B 10-Q · filed 2018-04-25 | $2.06B derived: sum of 2 quarters · filed 2019-02-13 | $2.65B derived: sum of 3 quarters · filed 2019-02-13 | $3.53B derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $527.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $1.12B derived: sum of 2 quarters · filed 2019-02-13 | $2.00B derived: sum of 3 quarters · filed 2019-02-13 | $2.46B 10-K · filed 2019-02-13 |
| 2016-09-30 | $593.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $1.47B derived: sum of 2 quarters · filed 2017-10-26 | $1.93B 10-Q · filed 2017-10-26 | $2.28B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $881.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $1.34B 10-Q · filed 2017-07-26 | $1.69B derived: sum of 3 quarters · filed 2018-02-13 | $2.37B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $458.00M 10-Q · filed 2017-04-27 | $806.00M derived: sum of 2 quarters · filed 2018-02-13 | $1.49B derived: sum of 3 quarters · filed 2018-02-13 | $2.78B derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $348.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $1.03B derived: sum of 2 quarters · filed 2018-02-13 | $2.33B derived: sum of 3 quarters · filed 2018-02-13 | $3.53B 10-K · filed 2018-02-13 |
| 2015-09-30 | $679.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $1.98B derived: sum of 2 quarters · filed 2016-10-28 | $3.18B 10-Q · filed 2016-10-28 | $3.42B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $1.30B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $2.50B 10-Q · filed 2016-07-29 | $2.74B derived: sum of 3 quarters · filed 2017-02-14 | $3.40B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $1.20B 10-Q · filed 2016-05-02 | $1.44B derived: sum of 2 quarters · filed 2017-02-14 | $2.10B derived: sum of 3 quarters · filed 2017-02-14 | $4.44B derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $237.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $904.00M derived: sum of 2 quarters · filed 2017-02-14 | $3.24B derived: sum of 3 quarters · filed 2017-02-14 | $4.20B 10-K · filed 2017-02-14 |
| 2014-09-30 | $667.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $3.00B derived: sum of 2 quarters · filed 2015-11-02 | $3.96B 10-Q · filed 2015-11-02 | $4.21B derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $2.34B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.29B 10-Q · filed 2015-08-05 | $3.54B derived: sum of 3 quarters · filed 2016-10-31 | $4.44B derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $957.00M 10-Q · filed 2015-04-27 | $1.20B derived: sum of 2 quarters · filed 2016-10-31 | $2.11B derived: sum of 3 quarters · filed 2016-10-31 | $3.12B derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $244.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $1.15B derived: sum of 2 quarters · filed 2016-10-31 | $2.17B derived: sum of 3 quarters · filed 2016-10-31 | $5.09B 8-K · filed 2016-10-31 |
| 2013-09-30 | $905.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $1.92B derived: sum of 2 quarters · filed 2014-10-29 | $4.85B 10-Q · filed 2014-10-29 | $5.96B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $1.02B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $3.94B 10-Q · filed 2014-08-05 | $5.06B derived: sum of 3 quarters · filed 2015-02-19 | $5.52B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $2.92B 10-Q · filed 2014-04-30 | $4.04B derived: sum of 2 quarters · filed 2015-02-19 | $4.50B derived: sum of 3 quarters · filed 2015-02-19 | $4.76B derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $1.58B derived: sum of 2 quarters · filed 2015-02-19 | $1.83B derived: sum of 3 quarters · filed 2015-02-19 | $1.99B 10-K · filed 2015-02-19 |
| 2012-09-30 | $461.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $718.00M derived: sum of 2 quarters · filed 2013-10-29 | $878.00M 10-Q · filed 2013-10-29 | $1.05B derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $257.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $417.00M 10-Q · filed 2013-08-06 | $591.00M derived: sum of 3 quarters · filed 2014-02-24 | $758.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $160.00M 10-Q · filed 2013-05-03 | $334.00M derived: sum of 2 quarters · filed 2014-02-24 | $501.00M derived: sum of 3 quarters · filed 2014-02-24 | $685.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $341.00M derived: sum of 2 quarters · filed 2014-02-24 | $525.00M derived: sum of 3 quarters · filed 2014-02-24 | $749.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | $167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $351.00M derived: sum of 2 quarters · filed 2012-11-06 | $575.00M 10-Q · filed 2012-11-06 | $787.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $184.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $408.00M 10-Q · filed 2012-08-08 | $620.00M derived: sum of 3 quarters · filed 2013-02-27 | $760.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $224.00M 10-Q · filed 2012-05-08 | $436.00M derived: sum of 2 quarters · filed 2013-02-27 | $576.00M derived: sum of 3 quarters · filed 2013-02-27 | $725.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $212.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $352.00M derived: sum of 2 quarters · filed 2013-02-27 | $501.00M derived: sum of 3 quarters · filed 2013-02-27 | $642.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $140.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $289.00M derived: sum of 2 quarters · filed 2011-11-04 | $430.00M 10-Q · filed 2011-11-04 | $533.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $149.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $290.00M 10-Q · filed 2011-08-08 | $393.00M derived: sum of 3 quarters · filed 2012-02-29 | $769.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $141.00M 10-Q · filed 2011-05-10 | $244.00M derived: sum of 2 quarters · filed 2012-02-29 | $620.00M derived: sum of 3 quarters · filed 2012-02-29 | $1.16B derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $479.00M derived: sum of 2 quarters · filed 2012-02-29 | $1.02B derived: sum of 3 quarters · filed 2012-02-29 | $1.44B 10-K · filed 2012-02-29 |
| 2009-09-30 | $376.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $915.00M derived: sum of 2 quarters · filed 2010-11-08 | $1.34B 10-Q · filed 2010-11-08 | $1.73B derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $539.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $964.00M 10-Q · filed 2010-08-09 | $1.36B derived: sum of 3 quarters · filed 2011-02-25 | $1.61B derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $425.00M 10-Q · filed 2010-05-07 | $818.00M derived: sum of 2 quarters · filed 2011-02-25 | $1.07B derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | $393.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $648.00M derived: sum of 2 quarters · filed 2011-02-25 | $1.02B 10-K · filed 2011-02-25 | |
| 2008-09-30 | $255.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $625.00M 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | $370.00M 10-Q · filed 2009-08-10 | |||
| 2007-12-31 | $454.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |